TI - Design , characterization , and structure of a biologically active single - chain mutant of human <prot>  IFN - gamma </prot>  .
PG - 169 - 79 AB - A mutant form of human <prot>  interferon - gamma </prot>  ( <p1  pair=1 >  <p1  pair=2 >  <prot>  <prot>  IFN - gamma </prot>  SC1 </prot>  </p1>  </p1>  ) that binds one <p2  pair=1 >  <prot>  <prot>  <prot>  IFN - gamma </prot>  receptor </prot>  alpha chain </prot>  </p2>  ( <p2  pair=2 >  <prot>  <prot>  IFN - gamma </prot>  R alpha </prot>  </p2>  ) has been designed and characterized .
 <prot>  <prot> IFN - gamma </prot>  SC1 </prot>  was derived by linking the two peptide chains of the <p1  pair=3 >  <p2  pair=3 >  <prot>  IFN - gamma </prot>  </p2>  </p1>  dimer by a seven - residue linker and changing His111 in the first chain to an aspartic acid residue .
Isothermal titration calorimetry shows that <p1  pair=4 >  <prot>  <prot>  IFN - gamma </prot>  SC1 </prot>  </p1>  forms a 1:1 complex with its high - affinity receptor ( <p2  pair=4 >  <prot>  <prot>  IFN - gamma </prot>  R alpha </prot>  </p2>  ) with an affinity of 27 ( + / - 9 ) nM .
The crystal structure of <prot>  <prot>  IFN - gamma </prot>  SC1 </prot>  has been determined at 2.9 A resolution from crystals grown in 1.4 M citrate solutions at pH 7.6 .
Comparison of the wild - type receptor - binding domain and the Asp111 - containing domain of <prot>  <prot>  IFN - gamma </prot>  SC1 </prot>  show that they are structurally equivalent but have very different electrostatic surface potentials .
As a result , surface charge rather than structural changes is likely responsible for the inability of the His111 -- GTTTTT Asp domain of to bind <prot>  IFN - gamma R alpha </prot>  .
The AB loops of <prot>  IFN - gamma SC1 </prot>  adopt conformations similar to the ordered loops of <prot>  IFN - gamma </prot>  observed in the crystal structure of the <p1  pair=5 >  <prot>  IFN - gamma </prot>  </p1>  / <p2  pair=5 >  <prot>  <prot>  IFN - gamma </prot>  R alpha </prot>  </p2>  complex .
Thus , <prot>  <prot>  IFN - gamma </prot>  R alpha </prot>  binding does not result in a large conformational change in the AB loop as previously suggested .
The structure also reveals the final six C - terminal amino acid residues of <prot>  <prot>  IFN - gamma </prot>  SC1 </prot>  ( residues 253 - 258 ) that have not been observed in any other reported <prot>  IFN - gamma </prot>  structures .
Despite binding to only one <p1  pair=6 >  <prot>  <prot>  IFN - gamma </prot>  R alpha </prot>  </p1>  , <p2  pair=6 >  <prot>  IFN - gamma SC1 </prot>  </p2>  is biologically active in cell proliferation , MHC class I induction , and anti - viral assays .
This suggests that one domain of <p1  pair=7 >  <p1  pair=8 >  <prot>  IFN - gamma </prot>  </p1>  </p1>  is sufficient to recruit <p2  pair=7 >  <prot>  <prot>  IFN - gamma </prot>  R alpha </prot>  </p2>  and <p2  pair=8 >  <prot>  IFN - gamma </prot>  R beta </p2>  into a complex competent for eliciting biological activity .
The current data are consistent with the main role of the <p1  pair=9 >  <p2  pair=9 >  <prot>  IFN - gamma </prot>  </p2>  </p1>  dimer being to decrease the dissociation constant of <prot>  IFN - gamma </prot>  for its cellular receptors .
AD - Center for Macromolecular Crystallography , University of Alabama ,
